GSE149901 3 V 1 ANLOTINIB HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE149901 3 V 1 ANLOTINIB HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE149901 3 V 1 ANLOTINIB HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE149901 3 V 1 ANLOTINIB HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE149901 3 V 1 ANLOTINIB HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

H4 clustered histone 15

Gene

H2A clustered histone 19

Gene

H2A clustered histone 4

Gene

tripartite motif containing 31

Gene

cytokine receptor like factor 2

Gene

neuropeptide Y receptor Y4-2

Gene

dynein axonemal heavy chain 2

Gene

cytochrome c oxidase copper chaperone COX17

Gene

short chain dehydrogenase/reductase family 42E, member 1

Gene

gamma-glutamyltransferase 5

  • Gene

    H4 clustered histone 15


  • Gene

    H2A clustered histone 19


  • Gene

    H2A clustered histone 4


  • Gene

    tripartite motif containing 31


  • Gene

    cytokine receptor like factor 2


  • Gene

    neuropeptide Y receptor Y4-2


  • Gene

    dynein axonemal heavy chain 2


  • Gene

    cytochrome c oxidase copper chaperone COX17


  • Gene

    short chain dehydrogenase/reductase family 42E, member 1


  • Gene

    gamma-glutamyltransferase 5

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.